Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Marksans Pharma Ltd.
BSE Code 524404
ISIN Demat INE750C01026
Book Value (Rs) 26.24
NSE Code MARKSANS
Dividend Yield % 0.32
Market Cap(Rs Mn) 71509.24
TTM PE(x) 60.31
TTM EPS(Rs) 2.62
Face Value (Rs) 1  
Type:
(Rs. in Million)
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax3376.532475.113021.641571.721043.07
Adjustment742.38353.07565.66420.38318.84
Changes In working Capital-1114.65-1107.02-1316.10591.17-817.92
Cash Flow after changes in Working Capital3004.261721.162271.202583.27543.99
Cash Flow from Operating Activities2374.12992.571785.902333.27273.95
Cash Flow from Investing Activities-2592.12-843.91-448.49-595.84-134.80
Cash Flow from Financing Activities1978.29795.11-152.85-1135.54-207.77
Net Cash Inflow / Outflow1760.29943.771184.56601.89-68.62
Opening Cash & Cash Equivalents2064.061120.29937.27335.38397.17
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations0.020000
Closing Cash & Cash Equivalent3824.372064.062121.83937.27328.55